Duska LR - Search Results

1

Top advances of the year: Cervical cancer.

Podwika SE, Duska LR. Podwika SE, et al. Among authors: duska lr. Cancer. 2023 Mar 1;129(5):657-663. doi: 10.1002/cncr.34617. Epub 2023 Jan 7. Cancer. 2023. PMID: 36609769 Free PMC article.

2

Defining the extent of cables loss in endometrial cancer subtypes and its effectiveness as an inhibitor of cell proliferation in malignant endometrial cells in vitro and in vivo.

DeBernardo RL, Littell RD, Luo H, Duska LR, Oliva E, Kirley SD, Lynch MP, Zukerberg LR, Rueda BR. DeBernardo RL, et al. Among authors: duska lr. Cancer Biol Ther. 2005 Jan;4(1):103-7. doi: 10.4161/cbt.4.1.1433. Epub 2005 Jan 8. Cancer Biol Ther. 2005. PMID: 15662117

3

Clinically significant venous thromboembolism after gynecologic surgery.

Schorge JO, Goldhaber SZ, Duska LR, Goodman A, Feldman S. Schorge JO, et al. Among authors: duska lr. J Reprod Med. 1999 Aug;44(8):669-73. J Reprod Med. 1999. PMID: 10483535

4

Epithelial ovarian carcinoma in the reproductive age group.

Duska LR, Chang YC, Flynn CE, Chen AH, Goodman A, Fuller AF, Nikrui N. Duska LR, et al. Cancer. 1999 Jun 15;85(12):2623-9. doi: 10.1002/(sici)1097-0142(19990615)85:12<2623::aid-cncr19>3.0.co;2-o. Cancer. 1999. PMID: 10375111

5

Advances in the surgical management of ovarian cancer.

Horowitz NS, Duska LR. Horowitz NS, et al. Among authors: duska lr. J Reprod Med. 2005 Jun;50(6):454-66. J Reprod Med. 2005. PMID: 16050570 Review.

6

Severe gastrointestinal complications in the era of image-guided high-dose-rate intracavitary brachytherapy for cervical cancer.

Trifiletti DM, Tyler Watkins W, Duska L, Libby BB, Showalter TN. Trifiletti DM, et al. Clin Ther. 2015 Jan 1;37(1):49-60. doi: 10.1016/j.clinthera.2014.11.003. Epub 2014 Nov 28. Clin Ther. 2015. PMID: 25444669

7

Does one size fit all? The updated ovarian cancer staging: Still a work in progress.

Duska LR, Kohn EC. Duska LR, et al. Cancer. 2015 Oct 1;121(19):3384-6. doi: 10.1002/cncr.29521. Epub 2015 Jun 25. Cancer. 2015. PMID: 26110592 Free article. No abstract available.

8

Cervical Cancer: The Next Generation of Prevention, Detection, and Treatment.

Duska LR. Duska LR. Clin Ther. 2016 Mar;38(3):446-8. doi: 10.1016/j.clinthera.2016.02.013. Clin Ther. 2016. PMID: 26993033 No abstract available.

9

Mesothelium expression of vascular cell adhesion molecule-1 (VCAM-1) is associated with an unfavorable prognosis in epithelial ovarian cancer (EOC).

Scalici JM, Arapovic S, Saks EJ, Atkins KA, Petroni G, Duska LR, Slack-Davis JK. Scalici JM, et al. Among authors: duska lr. Cancer. 2017 May 15;123(6):977-984. doi: 10.1002/cncr.30415. Epub 2016 Nov 7. Cancer. 2017. PMID: 28263384 Free PMC article.

10

Access to quality gynecologic oncology care: A work in progress.

Duska LR. Duska LR. Cancer. 2018 Jul 1;124(13):2680-2683. doi: 10.1002/cncr.31391. Epub 2018 May 16. Cancer. 2018. PMID: 29767847 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

161 results

Search Page